Pharma Environment https://pharmaenvironment.org Safer medicine for a safer world Fri, 29 Jun 2018 13:13:46 +0000 en-GB hourly 1 Performance of a constructed wetland in Grand Marais, Manitoba, Canada: Removal of nutrients, pharmaceuticals, and antibiotic resistance genes from municipal wastewater https://pharmaenvironment.org/performance-of-a-constructed-wetland-in-grand-marais-manitoba-canada-removal-of-nutrients-pharmaceuticals-and-antibiotic-resistance-genes-from-municipal-wastewater/ Wed, 09 Jan 2013 08:18:16 +0000 http://pharmaenvironment.org/?p=402 The overall objectives of this study were to characterize the presence of nutrients and emerging wastewater contaminants (pharmaceuticals, personal care products and antibiotic resistent genes) in the Grand Marais system and to evaluate the effectiveness of treatment wetlands in removal of these contaminants. It was hypothesized that the use of a treatment wetland would enhance degradation and elimination of these target compounds, and therefore, could be an option to complement the current lagoon wastewater treatment system in communities that rely on lagoon treatment alone. The results of this study indicate that while the treatment wetland may effectively attenuate an excess of nutrients and remove some micropollutants. it does not specifically target antibiotic resistant genes for removal.

Link to external pdf

]]> Removal of pharmaceutical residues by ferrate (VI) https://pharmaenvironment.org/removal-of-pharmaceutical-residues-by-ferrate-vi/ Wed, 09 Jan 2013 08:14:15 +0000 http://pharmaenvironment.org/?p=400 This paper aims to address the issue of the performance optimisation of pharmaceutical treatment in wastewater by ferrate (VI). The dose of ferrate, test water pHs and the physical and chemical properties of pharmaceuticals and their influece on the overall removal efficiency were studied in this work.Promising performance of ferrate in the treatment of real waste water effluent at both pH 6 and 8 and dose-range 1-5 mg Fe/L was observed. Removal efficiency of ciprofloxacin was the highest among the target compounds (63%), followed by naproxen (43%).

Link to external pdf

]]> Greenhouse gas accounting sector guidance for pharmaceutical products and medical devices https://pharmaenvironment.org/greenhouse-gas-accounting-sector-guidance-for-pharmaceutical-products-and-medical-devices/ Mon, 09 Jan 2012 08:21:16 +0000 http://pharmaenvironment.org/?p=404 The objective of the guidance is to enable consistent quantification of the GHG inventory of pharmaceutical products and medical devices. It is relevant for all pharmaceutical products and medical devices manufactured and administered in any country. To address this variability as well as the wide range of potential production and use pathways across the pharmaceutical and medical devices sector, the guidance uses a modular approach. The guidance addresses life cycle stages and processes in order to build a full life cycle profile for any type of pharmaceutical products or medical devices.

Link to external pdf

]]> Pharmaceuticals in a healthy environment – MistraPharma research 2008–2011 https://pharmaenvironment.org/pharmaceuticals-in-a-healthy-environment-mistrapharma-research-2008-2011/ Mon, 09 Jan 2012 00:26:00 +0000 http://pharmaenvironment.org/?p=393 This report provides an overview of the current knowledge, policy activities and future needs regarding human pharmaceuticals in the aquatic environment in Sweden and internationally.  The report explains the research programme developed by Mistrapharma from 2008 to 2011, which focused on researching and collecting information for the WikiPharma database that contains ecotoxicity data for pharmaceutical substances.

Link to pdf

]]> Enzymatic biodegradation of pharmaceutical wastewater https://pharmaenvironment.org/enzymatic-biodegradation-of-pharmaceutical-wastewater/ Sun, 09 Jan 2011 08:11:08 +0000 http://pharmaenvironment.org/?p=398 This paper reports on the use of yeast and amylase as active agents for effluent bioremediation. The addition of yeast or amylase increased the breakdown of the organic matter present in a pharmaceutical effluent by microorganisms therefore aiding remediation. Yeast yelded better results than amylase.

External link to pdf

]]> Application of anaerobic biotechnology for pharmaceutical wastewater treatment https://pharmaenvironment.org/application-of-anaerobic-biotechnology-for-pharmaceutical-wastewater-treatment/ Sat, 09 Jan 2010 00:16:51 +0000 http://pharmaenvironment.org/?p=390 The anaerobic treatment system is a promising alternative for pharmaceutical wastewater treatment. This report is a case study of a laboratory investigation into the treatment of pharmaceutical wastewater containing the antibiotic Tylosin in an anaerobic reactor. Specifically, the research sought to determine whether the anaerobic reactor could be used as a pre-treatment system at an existing pharmaceutical production plant. The reactor showed efficient substrate removal at low organic loading rates by promoting efficient chemical oxygen demand reduction. Under these conditions, an average of 95% Tylosin reduction was achieved in the up-flow anaerobic stage reactor. However, changes in the organic load reduced removal efficiency.

External link to pdf

]]>